HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniela Meco Selected Research

namitecan

12/2012Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.
7/2012The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniela Meco Research Topics

Disease

14Neoplasms (Cancer)
01/2021 - 08/2003
6Neuroblastoma
12/2012 - 10/2005
5Rhabdomyosarcoma
07/2012 - 08/2003
4Ependymoma
02/2021 - 09/2012
4Glioma (Gliomas)
01/2021 - 12/2006
4Medulloblastoma
01/2014 - 06/2009
2Primitive Neuroectodermal Tumors (PNET)
12/2012 - 06/2009
2Sarcoma (Soft Tissue Sarcoma)
07/2012 - 08/2003
1Carcinogenesis
01/2021
1Weight Loss (Weight Reduction)
12/2012
1Glioblastoma (Glioblastoma Multiforme)
12/2006
1Necrosis
09/2003
1Carcinoma (Carcinomatosis)
09/2003
1Fibrosarcoma
08/2003
1Neoplasm Metastasis (Metastasis)
08/2003

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
02/2021 - 08/2003
4Irinotecan (Camptosar)FDA LinkGeneric
12/2012 - 09/2005
3Phosphotransferases (Kinase)IBA
01/2021 - 10/2005
3CamptothecinIBA
12/2012 - 10/2005
3ErbB Receptors (EGF Receptor)IBA
09/2012 - 12/2006
3TrabectedinIBA
09/2005 - 08/2003
2Proteins (Proteins, Gene)FDA Link
02/2021 - 01/2014
2Nerve Growth Factor (NGF)IBA
01/2021 - 01/2019
2Epidermal Growth Factor (EGF)IBA
11/2017 - 09/2012
2namitecanIBA
12/2012 - 07/2012
2AEE 788 (AEE788)IBA
09/2012 - 10/2010
2Gefitinib (Iressa)FDA Link
09/2012 - 06/2009
2RetinoidsIBA
08/2012 - 03/2007
23- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA
08/2012 - 03/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2012 - 10/2010
2ST 1481 (Gimatecan)IBA
09/2010 - 10/2005
2Imatinib Mesylate (Gleevec)FDA Link
03/2007 - 10/2005
2Topotecan (Hycamtin)FDA LinkGeneric
03/2007 - 10/2005
1Histones (Histone)IBA
02/2021
1OTX015IBA
02/2021
1trkA ReceptorIBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021
1AZD 6244IBA
01/2021
1Biological ProductsIBA
01/2021
1Nerve Growth Factors (Neurotrophins)IBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1TropomyosinIBA
01/2021
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021
1Tyrosine Kinase InhibitorsIBA
11/2017
1MitogensIBA
11/2017
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2017
1Etoposide (VP 16)FDA LinkGeneric
08/2014
1Temozolomide (Temodar)FDA LinkGeneric
08/2014
1DNA (Deoxyribonucleic Acid)IBA
08/2014
1NestinIBA
01/2014
1Estrogens (Estrogen)FDA Link
01/2014
1Cyclin-Dependent Kinase Inhibitor p21IBA
01/2014
1Glial Fibrillary Acidic ProteinIBA
01/2014
1Phosphopyruvate Hydratase (Enolase)IBA
01/2014
1Estrogen ReceptorsIBA
01/2014
1Mitogen-Activated Protein Kinase 3IBA
09/2012
1Antineoplastic Agents (Antineoplastics)IBA
09/2012
1Caspase 8 (Caspase-8)IBA
08/2012
1Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2012
1Cytostatic AgentsIBA
08/2012
1Type I DNA Topoisomerases (Topoisomerase I)IBA
07/2012
1ChemokinesIBA
07/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2010
1LactonesIBA
09/2010
1Platelet-Derived Growth Factor alpha ReceptorIBA
12/2006
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2006
1NucleotidesIBA
12/2006
1Tyrosine (L-Tyrosine)FDA Link
10/2005
1tyrosine receptor (receptor, tyrosine)IBA
10/2005
1BilirubinIBA
09/2003
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
09/2003
1Dexamethasone (Maxidex)FDA LinkGeneric
09/2003
1Alkaline PhosphataseIBA
09/2003
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2003

Therapy/Procedure

3Therapeutics
02/2021 - 08/2012